Aniracetam
| Aniracetam | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 219.24 g/mol [1] |
| Predicted LogP | 1.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C12H13NO3 [1] |
| IUPAC name | 1-(4-methoxybenzoyl)pyrrolidin-2-one [1] |
| SMILES | COC1=CC=C(C=C1)C(=O)N2CCCC2=O [1] |
| InChI | InChI=1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3 [1] |
| InChIKey | ZXNRTKGTQJPIJK-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 0.5 hours[2] |
Aniracetam (also known as Draganon, Sarpul, 1-(4-Methoxybenzoyl)-2-pyrrolidinone, Ro 13-5057, 1-p-Anisoyl-2-pyrrolidinone, Ro-13-5057, 1-anisoyl-2-pyrrolidinone, 1-p-anisoylpyrrolidin-2-one, NSC-758223 or Ro-135057) is a
Chemistry
Stereochemistry []
Aniracetam is a achiral mixture.
Druglikeness
Lipinski's rule of five
Aniracetam matches Lipinski's rule of five.Pharmacology
ATC Classification
In the nervous system (N) aniracetam acts as a stimulant (N06B), aniracetam (N06BX11), other psychostimulants and nootropic (N06BX) and psychoanaleptic (N06).[1]Legal status []
- Australia: Aniracetam is a S4 substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 2196, Aniracetam. Accessed June 12, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2196
Roncari G. Human Pharmacokinetics of Aniracetam. Drug Investigation. June 1, 1993; 5(S1):68–72.